Literature DB >> 12044152

DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.

Daniel Lafitte1, Valérie Lamour, Philippe O Tsvetkov, Alexander A Makarov, Michel Klich, Pierre Deprez, Dino Moras, Claudette Briand, Robert Gilli.   

Abstract

DNA gyrase is a major bacterial protein that is involved in replication and transcription and catalyzes the negative supercoiling of bacterial circular DNA. DNA gyrase is a known target for antibacterial agents since its blocking induces bacterial death. Quinolones, coumarins, and cyclothialidines have been designed to inhibit gyrase. Significant improvements can still be envisioned for a better coumarin-gyrase interaction. In this work, we obtained the crystal costructures of the natural coumarin clorobiocin and a synthetic analogue with the 24 kDa gyrase fragment. We used isothermal titration microcalorimetry and differential scanning calorimetry to obtain the thermodynamic parameters representative of the molecular interactions occurring during the binding process between coumarins and the 24 kDa gyrase fragment. We provide the first experimental evidence that clorobiocin binds gyrase with a stronger affinity than novobiocin. We also demonstrate the crucial role of both the hydroxybenzoate isopentenyl moiety and the 5'-alkyl group on the noviose of the coumarins in the binding affinity for gyrase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044152     DOI: 10.1021/bi0159837

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

2.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

Review 3.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

4.  Biological activities of novel gyrase inhibitors of the aminocoumarin class.

Authors:  Christine Anderle; Martin Stieger; Matthew Burrell; Stefan Reinelt; Anthony Maxwell; Malcolm Page; Lutz Heide
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

5.  3-{2-[2-(3-Hy-droxy-benzyl-idene)hydrazin-1-yl]-1,3-thia-zol-4-yl}-2H-chromen-2-one hemihydrate.

Authors:  Afsheen Arshad; Hasnah Osman; Kit Lam Chan; Jia Hao Goh; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

6.  Stathmin/Op18 is a novel mediator of vinblastine activity.

Authors:  Francois Devred; Philipp O Tsvetkov; Pascale Barbier; Diane Allegro; Susan Band Horwitz; Alexander A Makarov; Vincent Peyrot
Journal:  FEBS Lett       Date:  2008-06-25       Impact factor: 4.124

7.  Extension of the tryptophan chi2,1 dihedral angle-W3 band frequency relationship to a full rotation: correlations and caveats.

Authors:  Laura J Juszczak; Ruel Z B Desamero
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

8.  Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.

Authors:  David A Ostrov; José A Hernández Prada; Patrick E Corsino; Kathryn A Finton; Nhan Le; Thomas C Rowe
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

9.  Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.

Authors:  Ute Galm; Stefanie Heller; Stuart Shapiro; Malcolm Page; Shu-Ming Li; Lutz Heide
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

Authors:  A Kotsiou; E Diamanti; A Potamianou; H Parara; J Vovou; C Perisanidis; C Tes; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.